HealthCor Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-130,290
Closed -$23.6M 83
2021
Q3
$23.6M Buy
130,290
+12,330
+10% +$2.24M 1.02% 28
2021
Q2
$23.8M Sell
117,960
-548,500
-82% -$111M 0.95% 34
2021
Q1
$143M Buy
666,460
+83,170
+14% +$17.9M 5.07% 2
2020
Q4
$138M Buy
583,290
+220,900
+61% +$52.2M 5.32% 3
2020
Q3
$98.6M Buy
362,390
+336,770
+1,314% +$91.6M 3.95% 12
2020
Q2
$7.44M Buy
+25,620
New +$7.44M 0.31% 39
2020
Q1
Sell
-65,860
Closed -$14.4M 60
2019
Q4
$14.4M Sell
65,860
-613,830
-90% -$134M 0.51% 43
2019
Q3
$115M Buy
679,690
+141,250
+26% +$23.9M 4.35% 5
2019
Q2
$98.7M Buy
538,440
+199,670
+59% +$36.6M 3.83% 6
2019
Q1
$62.3M Buy
338,770
+145,960
+76% +$26.8M 2.52% 15
2018
Q4
$32M Sell
192,810
-9,370
-5% -$1.55M 1% 26
2018
Q3
$39M Sell
202,180
-143,370
-41% -$27.6M 1.29% 28
2018
Q2
$58.7M Buy
345,550
+195,760
+131% +$33.3M 1.86% 21
2018
Q1
$24.4M Sell
149,790
-575,210
-79% -$93.7M 0.83% 35
2017
Q4
$109M Buy
725,000
+690,050
+1,974% +$103M 3.54% 13
2017
Q3
$5.31M Sell
34,950
-573,476
-94% -$87.2M 0.18% 33
2017
Q2
$78.4M Sell
608,426
-416,574
-41% -$53.7M 2.83% 12
2017
Q1
$112M Buy
+1,025,000
New +$112M 5.14% 8
2016
Q1
Sell
-471,970
Closed -$59.4M 51
2015
Q4
$59.4M Sell
471,970
-178,030
-27% -$22.4M 3.61% 12
2015
Q3
$67.7M Buy
650,000
+200,000
+44% +$20.8M 3.81% 12
2015
Q2
$55.6M Buy
450,000
+175,000
+64% +$21.6M 2.8% 12
2015
Q1
$32.4M Buy
+275,000
New +$32.4M 1.55% 21
2014
Q4
Hold
0
50
2014
Q3
Sell
-250,000
Closed -$23.7M 53
2014
Q2
$23.7M Buy
+250,000
New +$23.7M 1.19% 28
2013
Q3
Sell
-775,000
Closed -$62M 62
2013
Q2
$62M Buy
+775,000
New +$62M 3.75% 8